Clinical Trials List
Protocol NumberMRX-701
Completed
2021-12-31 - 2024-06-30
Phase II
Terminated3
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- SHENG-YANG HUANG Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林文熙 Division of Pediatrics
- 張凱琪 Division of Pediatrics
- YEN-HSUAN NI Division of Pediatrics
- 吳嘉峯 Division of Pediatrics
- 許文明 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
75 participants
